PHLEBOPROTECTORS BASED ON FLAVONOIDS: DOSAGE FORMS, BIOPHARMACEUTICAL CHARACTERISTICS, TECHNOLOGICAL FEATURES
Open Access
- 17 May 2021
- journal article
- research article
- Published by Volgograd State Medical University in Pharmacy & Pharmacology
- Vol. 8 (6) , 405-415-415
Abstract
Micronized purified flavonoid fraction (MPFF) is the original phlebotropic drug. Its marketed form (Detralex®) consists of 90% diosmin and 10% of other flavonoids. Calculated as hesperidin, it is the most widely used drug today. Diosmin and hesperidin, which are parts of the majority of venoactive drugs, are sparingly water-soluble compounds, and this feature can effect on their clinical efficacy. One of the ways to increase the solubility of these compounds leading to an increase in bioavailability, is the micronization of the active ingredients.The aim of the investigation is a comparative determination of the dynamics and dissolution efficiency of the drugs containing bioflavonoid fractions in the dissolution test, as well as the analysis of the micronization degree and its impact on technology and biopharmaceutical parameters.Materials and methods. A biopharmaceutical release profile was determined using HPLC. Disintegration, characteristics of the shape and size of the tablets’ particles were determined according to the methods of the State Pharmacopoeia of the XIV-th edition.Results. The objects created with the use of diosmin and hesperidin, have been considered in detail. The role of technological solutions in relation to the corresponding dosage forms is notified. Detailed biopharmaceutical characteristics have been established with a choice of HPLC-based release control methodology. All the drugs in this group have a low water solubility leading to the maximum bioavailability for Detralex® which is about 1.26%; and no more than 0.2% for other analyzed models.Conclusion. Detralex® dominates among the analyzed objects (tablets) in terms of the release rate. With regard to the overall quantitative indicators of release, the actual numbers are quite low, which is associated with the poor water solubility of the active substances.Keywords
This publication has 7 references indexed in Scilit:
- Review of modern phlebotrophic preparations based on flavonoids as perspective endothelioprotectors in the treatment of chronic diseases of the veinsAmbulatornaya khirurgiya = Ambulatory Surgery (Russia), 2019
- COMPARATIVE STUDY OF THE ORIGINAL TECHNOLOGY OF MICRONIZATION OF THE PURIFIED FLAVONOID FRACTION OF “DETRALEX®” AND THE TECHNOLOGY OF MICRONIZATION OF DRUGS D AND N OF THE UKRAINIAN MANUFACTURERSAsian Journal of Pharmaceutical and Clinical Research, 2018
- Enhancement of the water solubility and antioxidant activity of hesperidin by chitooligosaccharideJournal of the Science of Food and Agriculture, 2017
- Spectroscopic and structural studies of the diosmin monohydrate and anhydrous diosminInternational Journal of Pharmaceutics, 2017
- Evaluating the pharmaceutical equivalence of drugs in the registration stagePharmaceutical Chemistry Journal, 2009
- Venous Leg Ulcer: A Meta-analysis of Adjunctive Therapy with Micronized Purified Flavonoid FractionEuropean Journal of Vascular and Endovascular Surgery, 2005
- Comparison of the Absorption of Micronized (Daflon 500® mg) and Nonmicronized 14C‐diosmin Tablets After Oral Administration to Healthy Volunteers by Accelerator Mass Spectrometry and Liquid Scintillation CountingJournal of Pharmaceutical Sciences, 2002